News | Breast Imaging | July 16, 2021

Volpara now holds 98 granted patents across 27 countries

Volpara now holds 98 granted patents across 27 countries

July 16, 2021 — Volpara has recently been granted another patent by the European Patent Office, raising the total number of patents for the New Zealand-based health tech company to 98. This latest patent, effective across 25 European countries, outlines the Volpara method of image quantification, used in multiple instances across the Volpara Breast Health Platform product suite.

This latest patent highlights improved analysis of several quantitative measures from low dose images, enabling highly accurate assessment of a woman's breast composition at an early age, and calculation of her baseline risk of breast cancer. In addition to improving outcomes for women, the improvements will help optimize clinical workflow.

Research studies are beginning to suggest patients receive a baseline mammogram to assess their breast density and breast cancer risk before they reach the screening age of 40. A patient who receives a high breast cancer risk score may be directed to begin annual screenings earlier than usual.

One of the concerns with offering women between the ages of 25 and 30 a baseline screening exam has been the effect of the exam's radiation. High-sensitivity, low-dose imaging has the potential to offer patients a way around this issue — a solution in line with Volpara's aim to achieve personalized breast cancer screening for all women.

"Securing our 98th patent is another major step forward for the company, re-affirming our position as a leading innovator in the medical imaging space, and a testament to our R&D team who are constantly pushing the boundaries in novel and important directions, ever seeking to improve the early detection of cancer," said Volpara Health CEO Ralph Highnam.

This patent, together with the entire Volpara patent portfolio, serves to protect all the company's products. In sum, these patents are effective across 27 countries, including most of Europe, the US, and China.

"These patents work together with Volpara's other international intellectual property rights to facilitate the sales and growth strategy for Volpara's product line, including software geared toward patient reporting and communication, image/exam quality monitoring and feedback, and automated breast density calculations, as well as a full risk program," said Volpara Health CFO Craig Hadfield.

Early cancer detection is key to fulfilling the Volpara mission to eliminate late-stage breast cancer and save families from cancer.

For more information:

Related Content

News | Clinical Trials

February 8, 2023 — Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at ...

Time February 08, 2023
News | Ultrasound Women's Health

February 8, 2023 — Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound ...

Time February 08, 2023
News | Breast Density

February 6, 2023 — Awareness of breast density appears to increase one’s perceived breast cancer risk for a short time ...

Time February 06, 2023
News | Radiology Business

February 2, 2023 — Five additional imaging centers across Allegheny Health Network (AHN) have been recognized by the ...

Time February 02, 2023
News | MRI Breast

February 1, 2023 — Compared to other common supplemental screening methods, breast MRI was superior at detecting breast ...

Time February 01, 2023
News | Radiation Therapy

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
News | Stereotactic Breast Imaging

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
Feature | Radiology Imaging | By Melinda Taschetta-Millane

Have you read the January/February 2023 issue of Imaging Technology News? If not, take some time out of your busy ...

Time January 24, 2023
Subscribe Now